Amedeo Smart

Free Medical Literature Service


 

Amedeo

Stem Cell Research

  Free Subscription

Articles published in
Cancer Res
    February 2024
  1. YAN L, Wu M, Wang T, Yuan H, et al
    Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming that Drives Immune Evasion.
    Cancer Res. 2024 Feb 9. doi: 10.1158/0008-5472.CAN-23-2390.
    >> Share

    January 2024
  2. ZHANG H, Du Z, Tu C, Zhou X, et al
    Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma.
    Cancer Res. 2024;84:39-55.
    >> Share

    December 2023
  3. XIA L, Liu JY, Yang MY, Zhang XH, et al
    Osimertinib covalently binds to CD34 and eliminates myeloid leukemia stem/progenitor cells.
    Cancer Res. 2023 Dec 14. doi: 10.1158/0008-5472.CAN-23-1632.
    >> Share

    November 2023
  4. GUO X, Qiu W, Wang C, Qi Y, et al
    Neuronal activity promotes glioma progression by inducing proneural-to-mesenchymal transition in glioma stem cells.
    Cancer Res. 2023 Nov 14. doi: 10.1158/0008-5472.CAN-23-0609.
    >> Share

    September 2023
  5. YIN J, Seo Y, Rhim J, Jin X, et al
    Crosstalk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells.
    Cancer Res. 2023 Sep 25. doi: 10.1158/0008-5472.CAN-22-3965.
    >> Share

    August 2023
  6. JONES CL
    Turning Down the Temperature on Leukemia Stem Cells.
    Cancer Res. 2023;83:2441-2442.
    >> Share

    July 2023
  7. LI L, Jensen RA
    Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells.
    Cancer Res. 2023;83:2096-2104.
    >> Share

    June 2023
  8. GRIESSINGER E, Pereira-Martins D, Nebout M, Bosc C, et al
    Oxidative phosphorylation fueled by fatty acid oxidation sensitizes leukemic stem cells to cold.
    Cancer Res. 2023 Jun 5:CAN-23-1006. doi: 10.1158/0008-5472.CAN-23-1006.
    >> Share

  9. LOS-DE VRIES GT, Stathi P, Rutkens R, Hijmering NJ, et al
    Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell.
    Cancer Res. 2023;83:1917-1927.
    >> Share

    April 2023
  10. GUETTA-TERRIER C, Karambizi D, Akosman B, Zepecki JP, et al
    Chi3l1 is a modulator of glioma stem cell states and a therapeutic target in glioblastoma.
    Cancer Res. 2023 Apr 27:CAN-21-3629. doi: 10.1158/0008-5472.CAN-21-3629.
    >> Share

    March 2023
  11. HUANG X, Zhang S, Tang J, Tian T, et al
    A self-propagating c-Met-SOX2 axis drives cancer-derived IgG signaling that promotes lung cancer cell stemness.
    Cancer Res. 2023 Mar 29:CAN-22-2733. doi: 10.1158/0008-5472.CAN-22-2733.
    >> Share

  12. CHAKRAVARTI M, Dhar S, Bera S, Sinha A, et al
    Terminally exhausted CD8+ T cells resistant to PD-1 blockade promote generation and maintenance of aggressive cancer stem cells.
    Cancer Res. 2023 Mar 27:CAN-22-3864. doi: 10.1158/0008-5472.CAN-22-3864.
    >> Share

  13. BOO HJ, Min HY, Park CS, Park JS, et al
    Dual impact of IGF2 on alveolar stem cell function during tobacco-induced injury repair and development of pulmonary emphysema and cancer.
    Cancer Res. 2023 Mar 27:CAN-22-3543. doi: 10.1158/0008-5472.CAN-22-3543.
    >> Share

  14. ZAMLER DB, Hu J
    Primitive Oligodendrocyte Precursor Cells Are Highly Susceptible to Gliomagenic Transformation.
    Cancer Res. 2023;83:807-808.
    >> Share

  15. OKA T, Higa T, Sugahara O, Koga D, et al
    Ablation of p57+ Quiescent Cancer Stem Cells Suppresses Recurrence After Chemotherapy of Intestinal Tumors.
    Cancer Res. 2023 Mar 7:CAN-22-2578. doi: 10.1158/0008-5472.CAN-22-2578.
    >> Share

    January 2023
  16. LAN L, Behrens A
    Are There Specific Cancer Stem Cell Markers?
    Cancer Res. 2023;83:170-172.
    >> Share

    December 2022
  17. ADEBAYO AK, Nakshatri H
    Modeling Preclinical Cancer Studies under Physioxia to Enhance Clinical Translation.
    Cancer Res. 2022;82:4313-4321.
    >> Share

    November 2022
  18. PIERI V, Gallotti AL, Drago D, Cominelli M, et al
    Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma.
    Cancer Res. 2022 Nov 21:CAN-22-0677. doi: 10.1158/0008-5472.CAN-22-0677.
    >> Share

  19. STEVENS LE, Peluffo G, Qiu X, Temko D, et al
    JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states.
    Cancer Res. 2022 Nov 21:CAN-22-0423. doi: 10.1158/0008-5472.CAN-22-0423.
    >> Share

  20. MARSHALL CH, Gondek LP, Luo J, Antonarakis ES, et al
    Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
    Cancer Res. 2022;82:4107-4113.
    >> Share

  21. PERRONE M, Chiodoni C, Lecchi M, Botti L, et al
    ATF3 reprograms the bone marrow niche in response to early breast cancer transformation.
    Cancer Res. 2022 Nov 1. pii: 710151. doi: 10.1158/0008-5472.CAN-22-0651.
    >> Share

    October 2022
  22. ATIYA HI, Frisbie L, Goldfeld E, Orellana T, et al
    Endometriosis-associated mesenchymal stem cells support ovarian clear cell carcinoma through iron regulation.
    Cancer Res. 2022 Oct 11. pii: 709712. doi: 10.1158/0008-5472.CAN-22-1294.
    >> Share

    September 2022
  23. FUJISHITA T, Kojima Y, Kajino-Sakamoto R, Mishiro-Sato E, et al
    The cAMP/PKA/CREB and TGF-beta/SMAD4 pathways regulate stemness and metastatic potential in colorectal cancer cells.
    Cancer Res. 2022 Sep 6. pii: 708953. doi: 10.1158/0008-5472.CAN-22-1369.
    >> Share

    July 2022
  24. LI Y, Wang T, Wan Q, Wang Q, et al
    TRAF4 maintains deubiquitination of Caveolin-1 to drive glioblastoma stemness and Temozolomide resistance.
    Cancer Res. 2022 Jul 27. pii: 707286. doi: 10.1158/0008-5472.CAN-21-3882.
    >> Share

  25. DHANYAMRAJU PK, Schell TD, Amin S, Robertson GP, et al
    Drug-Tolerant Persister Cells in Cancer Therapy Resistance.
    Cancer Res. 2022;82:2503-2514.
    >> Share

  26. LI D, Zhang Q, Li L, Chen K, et al
    beta2-microglobulin maintains glioblastoma stem cells and induces M2-like polarization of tumor-associated macrophages.
    Cancer Res. 2022 Jul 15. pii: 707040. doi: 10.1158/0008-5472.CAN-22-0507.
    >> Share

    June 2022
  27. MOK EH, Leung CO, Zhou L, Lei MML, et al
    Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma.
    Cancer Res. 2022 Jun 29. pii: 705310. doi: 10.1158/0008-5472.CAN-21-2934.
    >> Share

    May 2022
  28. HEINZ MC, Peters NA, Oost KC, Lindeboom RGH, et al
    Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage.
    Cancer Res. 2022;82:1953-1968.
    >> Share

  29. LEBLEU VS
    Plasticity Enables Cooperation among Heterogeneous Cancer Cell Populations to Support Metastatic Fitness.
    Cancer Res. 2022;82:1870-1871.
    >> Share

    April 2022
  30. WANG H, Xu H, Chen W, Cheng M, et al
    Rab13 sustains breast cancer stem cells by supporting tumor-stroma crosstalk.
    Cancer Res. 2022 Apr 8. pii: 694330. doi: 10.1158/0008-5472.CAN-21-4097.
    >> Share

    March 2022
  31. SAMANTA D, Park Y, Andrabi SA, Shelton LM, et al
    Correction: PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis.
    Cancer Res. 2022;82:1153.
    >> Share

  32. OSBORNE JK, Minna JD
    Lung Cancer Cell of Origin: Controversy and Clinical Translational Implications.
    Cancer Res. 2022;82:972-973.
    >> Share

    February 2022
  33. AUZMENDI-IRIARTE J, Otaegi-Ugartemendia M, Carrasco-Garcia E, Azkargorta M, et al
    Chaperone-mediated autophagy controls proteomic and transcriptomic pathways to maintain glioma stem cell activity.
    Cancer Res. 2022 Feb 7. pii: 0008-5472.CAN-21-2161.
    >> Share

    January 2022
  34. YIN H, Jing B, Xu D, Guo W, et al
    Identification of Active Bronchioalveolar Stem Cells as the Cell-of-Origin in Lung Adenocarcinoma.
    Cancer Res. 2022 Jan 19. pii: 0008-5472.CAN-21-2445.
    >> Share

    November 2021
  35. JUNG Y, Cackowski FC, Yumoto K, Decker AM, et al
    Correction: CXCL12gamma Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes.
    Cancer Res. 2021;81:5777.
    >> Share

  36. BERLIN C, Cottard F, Willmann D, Urban S, et al
    KMT9 controls stemness and growth of colorectal cancer.
    Cancer Res. 2021 Nov 4. pii: 0008-5472.CAN-21-1261.
    >> Share

    October 2021
  37. FISHER ML, Balinth S, Hwangbo Y, Wu C, et al
    BRD4 REGULATES TRANSCRIPTION FACTOR Np63alphaTO DRIVE A CANCER STEM CELL PHENOTYPE IN SQUAMOUS CELL CARCINOMAS.
    Cancer Res. 2021 Oct 25. pii: 0008-5472.CAN-21-0707.
    >> Share

  38. GOLDBERG L, Negi V, Chung YJ, Onozawa M, et al
    Mutant Idh2 Cooperates with a NUP98-HOXD13 Fusion to Induce Early Immature Thymocyte Precursor ALL.
    Cancer Res. 2021;81:5033-5046.
    >> Share

    September 2021
  39. SANJIV K, Calderon-Montano JM, Pham TM, Erkers T, et al
    MTH1 inhibitor TH1579 induces oxidative DNA damage and mitotic arrest in acute myeloid leukemia.
    Cancer Res. 2021 Sep 30. pii: 0008-5472.CAN-21-0061.
    >> Share

  40. LIU C, Qiang J, Deng Q, Xia J, et al
    ALDH1A1 activity in tumor-initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression.
    Cancer Res. 2021 Sep 27. pii: 0008-5472.CAN-21-1337.
    >> Share

  41. LOH JJ, Li TW, Zhou L, Wong TL, et al
    FSTL1 secreted by activated fibroblasts promotes hepatocellular carcinoma metastasis and stemness.
    Cancer Res. 2021 Sep 22. pii: 0008-5472.CAN-20-4226.
    >> Share

  42. YANG L, Sun J, Li M, Long Y, et al
    Oxidized low-density lipoprotein links hypercholesterolemia and bladder cancer aggressiveness by promoting cancer stemness.
    Cancer Res. 2021 Sep 3. pii: 0008-5472.CAN-21-0646.
    >> Share

    August 2021
  43. DUTTA A, Nath D, Yang Y, Le BT, et al
    CDK6 Is a Therapeutic Target in Myelofibrosis.
    Cancer Res. 2021;81:4332-4345.
    >> Share

    July 2021
  44. MAIFREDE S, Le BV, Nieborowska-Skorska M, Golovine K, et al
    TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors.
    Cancer Res. 2021 Jul 2. pii: 0008-5472.CAN-20-3761.
    >> Share

    June 2021
  45. CANO A, Lopez-Menendez C, Vazquez-Naharro A, Santos V, et al
    E2A modulates stemness, metastasis, and therapeutic resistance of breast cancer.
    Cancer Res. 2021 Jun 18. pii: 0008-5472.CAN-20-2685.
    >> Share

    May 2021
  46. MILLER SA, Policastro RA, Sriramkumar S, Lai T, et al
    LSD1 and aberrant DNA methylation mediate persistence of enteroendocrine progenitors that support BRAF mutant colorectal cancer.
    Cancer Res. 2021 May 25. pii: 0008-5472.CAN-20-3562.
    >> Share

  47. WANG X, Jia Y, Wen L, Mu W, et al
    Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome.
    Cancer Res. 2021;81:2745-2759.
    >> Share

  48. FRAU C, Jamard C, Delpouve G, Guardia GDA, et al
    Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy.
    Cancer Res. 2021;81:2730-2744.
    >> Share

  49. LI Y, Wang M, Yang M, Xiao Y, et al
    Nicotine-induced ILF2 facilitates nuclear mRNA export of pluripotency factors to promote stemness and chemoresistance in human esophageal cancer.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-4160.
    >> Share

    February 2021
  50. MENG Y, Zhao Q, An L, Jiao S, et al
    A TNFR2-hnRNPK axis promotes primary liver cancer development via activation of YAP signaling in hepatic progenitor cells.
    Cancer Res. 2021 Feb 22. pii: 0008-5472.CAN-20-3175.
    >> Share

    January 2021
  51. TAMIRO F, Weng AP, Giambra V
    Targeting leukemia-initiating cells in acute lymphoblastic leukemia (ALL).
    Cancer Res. 2021 Jan 7. pii: 0008-5472.CAN-20-2571.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016